Tcelna FDA Approval Status
FDA Approved: No
Brand name: Tcelna
Generic name: imilecleucel-T
Previous Name: Tovaxin
Company: Opexa Therapeutics, Inc.
Treatment for: Multiple Sclerosis
Tcelna (imilecleucel-T) is a personalized T-cell immunotherapy in development for the treatment of Secondary Progressive Multiple Sclerosis.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.